Comments
Loading...
Atea Pharmaceuticals (NASDAQ:AVIR) Stock, Earnings Estimates, EPS, And Revenue
Atea Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 26
EPS Estimate
$-0.290
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Atea Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Atea Pharmaceuticals (AVIR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $-0.37 | $-0.49 | 24.5 % |
| Jun 2024 | 2024-08-07 | $-0.48 | $-0.76 | 36.8 % |
| Mar 2024 | 2024-05-14 | $-0.75 | $-0.61 | -22.9 % |
| Dec 2023 | 2024-02-28 | $-0.47 | $-0.50 | 6.00 % |
Atea Pharmaceuticals (AVIR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2022 | 2022-05-10 | $0 | $3.33M | -100.0 % |
| Dec 2021 | 2022-02-28 | $192.18M | $85.73M | 124.2 % |
| Jun 2021 | 2021-08-12 | $60.39M | $57.99M | 4.14 % |
| Mar 2021 | 2021-05-13 | $65.99M | $48.63M | 35.7 % |
FAQ
When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?
Atea Pharmaceuticals (AVIR) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Atea Pharmaceuticals (NASDAQ:AVIR)?
The Actual EPS was $-0.37, which beat the estimate of $-0.49.
What were Atea Pharmaceuticals’s (NASDAQ:AVIR) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.